Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
14900
Descripción
The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain; ODM derived from: https://clinicaltrials.gov/show/NCT00188669
Link
https://clinicaltrials.gov/show/NCT00188669
Palabras clave
Versiones (2)
- 5/5/16 5/5/16 -
- 26/6/16 26/6/16 -
Subido en
5 de mayo de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Breast Neoplasms NCT00188669
Eligibility Breast Neoplasms NCT00188669
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT00188669
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
uicc tnm stage 0 (i.e. in situ disease), 1 or 2 breast cancer patients treated with conservative surgery and adjuvant radiotherapy with chronic breast pain or tenderness, with or without fibrosis, within 3 months to 3 years following completion of radiotherapy
boolean
C0150055|C0234233 (UMLS CUI [1])
ID.2
Item
age 18 to 75 years of age
boolean
C0001779 (UMLS CUI [1])
ID.3
Item
chronic symptoms localised to the breast treated with radiation, i.e. any one or more of the following- pain (not attributable to infection) or tenderness with or without associated oedema, fibrosis, necrosis or ulceration.
boolean
C0156323 (UMLS CUI [1])
ID.4
Item
breast pain (maximum in the previous 24 hours) measurable on a linear analogue scale with a length of 3cm or greater
boolean
C0024902 (UMLS CUI [1])
ID.5
Item
prior treatment with radiation to the affected area i.e. in tangential breast fields or boost area
boolean
C1522449 (UMLS CUI [1])
ID.6
Item
radiation completed at least 3 months and no longer than 3 years prior to study entry
boolean
C0011008 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
ID.7
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
ID.8
Item
active cellulitis in the breast
boolean
C0392003 (UMLS CUI [1])
ID.9
Item
active malignant disease
boolean
C0006826 (UMLS CUI [1])
ID.10
Item
any medical illness or condition judged likely by the local investigator to preclude safe administration of protocol treatment
boolean
ID.11
Item
contraindication to treatment with pentoxifylline (i.e. previously exhibited intolerance to pentoxifylline or other xanthines such as caffeine, theophylline or theobromine; recent cerebral and/or retinal haemorrhage; ischaemic heart disease; hypotension
boolean
C1301624 (UMLS CUI [1,1])
C0030899 (UMLS CUI [1,2])
C0030899 (UMLS CUI [1,2])
ID.12
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])